Publications by authors named "Lisa Lubsch"

Claim this Profile
P
Pediatric Pharmacy Association 2025 KIDs List of Key Potentially Inappropriate Drugs in Pediatrics.
Christopher McPherson, Rachel S Meyers, Jennifer Thackray, Danielle L Stutzman, Kimberly P Mills, Lisa Lubsch

J Pediatr Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacy specializations at a school of pharmacy: Development and implementation.
Carrie Vogler, Jared Sheley, Lisa Lubsch

Curr Pharm Teach Learn· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Weight Should Be Included on All Medication Prescriptions.
Lisa Lubsch, Katelin Kimler, Nicole Passerrello, Mindy Parman, Andrea Dunn

J Pediatr Pharmacol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series.
Hunter Ragan, Elizabeth Autry, Taryn Bomersback, Jennifer Hewlett, Lauren Kormelink, Lisa Lubsch

Pediatr Pulmonol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presumed adrenal insufficiency in neonates treated with corticosteroids for the prevention of bronchopulmonary dysplasia.
Justin B Josephsen, Brianna M Hemmann, Connie D Anderson, Brett M Hemmann, Paula M Buchanan, Lisa M Lubsch

J Perinatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis.
Ashlee Anderson, Lindsey McCoy, Rebecca S Pettit, Brittany A Wright, Lisa Lubsch

Pediatr Pulmonol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Statement on Pediatric Education at Schools of Pharmacy.
Christina L Cox, Timothy J Todd, Lisa Lubsch, Kristin C Klein, William A Prescott

Am J Pharm Educ· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ey Potentially nappropriate rugs in Pediatrics: The KIDs List.
Rachel S Meyers, Jennifer Thackray, Kelly L Matson, Christopher McPherson, Lisa Lubsch

J Pediatr Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label use of intravenous antimicrobials for inhalation in patients with cystic fibrosis.
Cameron J McKinzie, Lori Chen, Kim Ehlert, Alison G Grisso, Alaina Linafelter, Lisa Lubsch

Pediatr Pulmonol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
Chris Stockmann, Jared Olson, Jahidur Rashid, Lisa Lubsch, David C Young

J Clin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacy (organization) divide: A focus on the impact in pediatric pharmacy.
Lisa Lubsch, Chad Knoderer, Kristin C Klein

J Am Pharm Assoc (2003)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebulized Gentamicin as an Alternative to Nebulized Tobramycin for Tracheitis in Pediatric Patients.
Justin K Chen, Brittany L Martin-McNew, Lisa M Lubsch

J Pediatr Pharmacol Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection.
Peter J Mogayzel, Edward T Naureckas, Karen A Robinson, Cynthia Brady, Margaret Guill, Lisa Lubsch

Ann Am Thorac Soc· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Chris Stockmann, Catherine M T Sherwin, Jeffery T Zobell, Lisa Lubsch, David C Young

Pharmacotherapy· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.
Peter J Mogayzel, Edward T Naureckas, Karen A Robinson, Gary Mueller, Denis Hadjiliadis, Lisa Lubsch

Am J Respir Crit Care Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking cessation treatment for adolescents.
Julie P Karpinski, Erin M Timpe, Lisa Lubsch

J Pediatr Pharmacol Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral baclofen and clonidine for treatment of spasticity in children.
Lisa Lubsch, Rolf Habersang, Mark Haase, Sherry Luedtke

J Child Neurol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
Brittany Harris Sanders, Lisa M Lubsch, Donna S West

Ann Pharmacother· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of survivors of childhood cancer.
Michelle Condren, Lisa Lubsch, Trib S Vats

Indian J Pediatr· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis